An eyewitness told PETA that "blood soaked the water" at the San Diego park when one orca started attacking another in a tank in front of visitors.

Orca Bio’s T-cell immunotherapy candidate for blood cancers has more than doubled the number of patients surviving free of moderate-to-severe chronic graft versus host disease (GvHD). The Phase ...

This biotech believes its cancer treatment is the next big thing. Here’s why.

In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the rate at which patients survived without developing chronic graft ...

Orca Bio announces it met the primary endpoint in its pivotal Phase 3 clinical study for its lead allogeneic T-cell immunotherapy, Orca-T.

The rate of cGVHD-free survival was 78% at 1 year in patients who received Orca-T compared with 38% among patients who received standard allogeneic stem cell transplant for hematologic malignancies.

An endangered southern resident orca calf has been spotted again, and the whale research center is thrilled at the calf's appearance.

The orcas then bite the abdomen of their prey, allowing its blood to flow out before consuming its internal organs. “You can clearly see how all the members of the orca pod are trying to bring ...

An orca who made headlines in 2018 after she carried her dead calf on her head for more than two weeks and a distance of 1,000 miles has given birth again, according to the Center for Whale Research.

Orca Bio’s T-cell immunotherapy candidate for blood cancers has more than doubled the number of patients surviving free of moderate-to-severe chronic graft versus host disease (GvHD).